Immunic Inc. (IMUX) Misses Q4 EPS by 303c

Immunic Inc. (NASDAQ: IMUX) reported Q4 EPS of ($3.78), $3.03 worse than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• CareDx completes Naveris acquisition, adding cancer MRD testing
• Columbus McKinnon names John Linker as CFO, reaffirms FY2027 guidance